XENCOR (XE9 MU) stock market data APIs
€14.6345
0(0%)
as of December 12, 2025
Try our APIs with
free plan!
XENCOR Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for XE9.MU.
Prev. Close
14.6345
Open
14.6345
High
14.6345
Low
14.6345
52 wk Range
6.1-23.8
Market Cap
1 750 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get XENCOR data using free add-ons & libraries
Get XENCOR Fundamental Data
XENCOR Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
XENCOR News
New
Xencor Announces Extension of U.S. Patent Term on Certain Xtend™ Antibodies
-- Royalty term on Ultomiris® sales in the United States anticipated to continue into year-end 2028, extending term by three years -- -- Additional $100 million to $120 million in potential royalty ...
Xencor (XNCR): Assessing Valuation After Net Losses Narrow Sharply in Latest Earnings
Xencor (XNCR) just shared its third quarter earnings, revealing a sharp reduction in net loss compared to a year ago. Investors are paying close attention as the company’s financial turnaround conti...
Will Sharply Reduced Net Losses Signal a Turning Point for Xencor's (XNCR) Path to Profitability?
Xencor, Inc. reported its third quarter and nine-month 2025 financial results on November 5, showing net loss reductions to US$6.03 million and US$85.27 million, respectively, both significantly lower...
Xencor to Participate at Upcoming Investor Conferences
PASADENA, Calif., November 10, 2025--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
